i bc27f85be50b71b1 (304 page)

also Fractures

lhrombolyti�, 50

Infections, 629--630

electrocardiography in, 43

mecabolic, 689-692

hean ratc vari3bility in, 26-27

osteomyelitis, 629-630

management of, 50-53

physic3l therapy in, 237-258, 630

pathophysiology 111. 39-43

111 prolonged bed rest, 754t

physical therapy in, 3 1

soft tissue surgery in, 2 1 4-220

revasculari7.3UOn procedures 111.

experimental, 2 1 9-220

50-52

spine surgery in, 2 1 0-214

oxygen demand III exercise, 67

tmcrion in, 230-232

Myoglobin in cardiac evaluation, 30t, 3 1

exanllnnrion of, 1 60-169

Myopathy in cmical illness, 759

diagnostic tests in, 1 67- 169

Myotomes in musculoskelctal cX3rnin3-

functional mobility and safety

uon, 1 63, 1 64t, 165t

issues in, 1 65-1 67

history taking in, 1 60- 1 6 1

Nasal cannula for oxygen delivery, 7711

i n pain, 1 6 1

with humidificarion, 778f

physical examination in, 1 6 1 - 1 65

Nasoenteric feeding rubes, 799t-800t

radionuclide scans in. 1 68, 337t

Nasogastrlc tubes, 8001

r3nge of morion in, 163, 1 65, 1 66t

Naso-pharyngeal c:lthClCr for oxygen

upper and lower-quarter screens in,

deliver)" 772r-773r

1 63-165, 1 641,1 65r

Nasotracheal tntubation in mechanical

in hem3tologic disorders, 378t, 379

ventilation, 8 1 2

INDEX

957

Nausea and vomiting

anriparkinsonian, 321, 85 It

antiemetic agents in, 34 1 , 342, 846t-

diuretic, 867t

8471

muscle relaxant, 868t

in chemotherapy, 34 1 , 342

in electrical burns, 443

hematemesis in, 527

in HIV infection and AJDS, 635t,

in radiation therapy, 341

6361

Nebulizers, 800t

infections, 625-629

Neck

in intracranial pressure increase,

cancer of, 354-355

321-324

collar support for� 225t

neurosurgery in, 325-326

fractures of, 182, 183f, 1 84, 252t-

pathophysiology in, 305-321

2531

physical therapy in, 326-327, 356

traction applied (0, 231 t

postoperative, 872, 873

Neoplasms, 33 1-359. See also Tumors

in prolonged bed rest, 754r

Nephrectomy, 595-596

seizures, 3 1 6-318, 324t, 845t

Nephritis, interstitial, 578-579

in spine fractures, 1 82

Nephrolithiasis, 566, 579-580

syncope in, 3 1 9

surgery in, 596-597

traumatic, 305-310

Nephrolithotomy, 596

ulceration in, 471-472

Nephrons, 558

ventricular, 3 1 5-3 1 6

Nephropathy

i n viramin 812 deficiency, 406

in diabetes mellitus, 580-581

evaluation of, 277-305

immunoglobulin (gA, 574-575

in coma, vegetative state, and brain

Nephros(Omy

death, 756f, 757

percutaneous stone removal in, 596

coordination tests in, 299

urinary diversion in, 597, 598f

cranial nerve tests in, 287, 288t-

Nephrotic syndrome, 577-578

2921

Nerve conduction velocity studies, 304

diagnostic procedures in, 299-305

Nervous system, 259-327

history taking in, 278-2 8 1

anesthesia affecting, 872

mental status examination in, 282-

autonomic. See Au(Onomic nervous

286

system

mOtor function in, 294-297

and cardiovascular function, 1 0

observation in, 2 8 1

central. See Central nervous system

sensory function in, 298-299

conduction velocity in, 304

vision tests in, 287, 293-294

disorders of, 305-327

vital signs in, 287

bladder dysfunction in, 584

in hematologic disorders, 378t

in cancer, 333t, 356

peripheral. See Peripheral nervous syscerebrovascular, 3 1 2-3 1 5

tem

claudication in, 388

and respiratory function, 90, 92t

in compression from cast, 223

structure and function of, 260-277

in critical illness polyneuropathy,

Neuropathy

758-759

in critical illness, 758-759

degenerative, 3 1 9-321

in diabetes mellinls, 471-472, 681-684

in diabetes mellitus, 471-472, 681-

signs and symptoms of, 683t-684t

684

types of, 683t-684t

signs and symptoms of, 683t-

familial amyloidotic polyneuropathy,

6841

liver transplantation in, 7 1 3

types of, 683r-684t

i n HlV infection and AIDS, 635t,

drug therapy in, 325

6361

anticonvulsant, 845t

ulceration in, 471-472

958

AClITE CARE HANDBOOK FOR PHYSICAL THERAPISTS

Neurosurgery, 325-326

in musculoskeletal evaluarion, 1 61-

Neutropenia in chemotherapy, 343

162

Neutrophil coum

in neurologic evaluation, 281

in chemotherapy, 343

in respiratOry evaluation, 98-99

in infections, 610

in extra pleural disorders, 1 45(-

Nitrate preparations, 866t

147t

Nocturia, 561

111 obstructive disorders, t 3 1 t-

Non-rebreather masks for oxygen deliv134t

ery, 775t, 781 f

physical therapy based on, 1 54t

partial, 774t

in restrictive disorders, 138t-140t

Norepmephrlne, 668, 671

in ruberculosis therapy, 623

cardiac effects of, 1 1 r

in vascular evaluatIon, 367-368

target sites and actions of. 669t

in wounds, 480-482

urine levels of, 671

Obturator nerve, 278t

Nose,91t

Occipital lobc, 264t

Nosocomial infections, 607t, 614

OculomotOr nerve, 289t

amibiotic-resistam, 6 1 5-618

Odomoid process fracture, 2521

prevenuon of, 614, 615t, 639, 750

Olecranon fractures, 186, 188f, 257t

Nucleoside analogs in HIV infection and

Olfactory nerve, 2881

AIDS, 633

Oliguria, 561

5'-Nucleotidase levels, 5 1 9t

in acute renal failure, 570

Nutrition

Oncology, 331-359. See also Tumors

in anemia, 4 1 6, S66t

Opioid therapy, 879, 881 t-882t

in chemotherapy, 342

epidural, 882t

in diabetes mellitus, 674, 677

implanted pump for, 884t

and hypogl)'cemia, 685

in panem-controlled analgesia, 883t

in gastrointestinal disorders, 550-

OpportulllstlC infections, 607r

551

in IfIV mfcct10n and AIDS, 633-634

dysphagia affecting, 524-525

Optic nerve, 288t

and malabsorption syndromes,

Oral cavlry

535-536, 551

cancer of, 354, 355

gastrostOmy/jejunostomy rubes in,

risk factors in, 335t, 355

percutaneous endoscopic,

(unction in gastrolOtestinal system,

800t-801t

504t

in hypoparathyroidism, 689

Orders

nasoentcric feeding rubes in, 799t-

on comfort measures, 755

800t

do not resuscitate/do not intubate,

nasogastric rubes in, SOOt

755

and wound healing, 474-475

medIcal records on, 746

Nystatin in burns, 461 t

Orientation to person, place, and time,

assessment of, 283, 285r

Obesity, respiratory disorders in, 150

Orthopnea, l OOt

Observation and inspection

Orthoses, 225-229

in burns, 462

Osmosis, 587

in cardiac evaluation, 1 5-16

Osmotherapy in intracranial pressure

in gastrointestinal evaluation, 505-

increase, 324t

507,506f

Osmotic diurencs, 867t

abdominal quadrants in, 505, 50M

Osteomalacia, 69 1

in genitourinary evaluation, 562-563

OsteomyelItIS, 629-630

in hematologic evaluation, 377

Osteoporosis. 689-690

in infections, 607-608

Osteosarcoma, 333t, 3461